AAD 2026Abstract 74159
Pembrolizumab in Heavily Pretreated Cutaneous T-Cell Lymphoma
Outcomes from a Single-Center
Khoshniyati S, Sterling C, Rozati S
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Skin cancer & tumorsCutaneous lymphomaCancer drugs
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.1341 · Not in PubMed: details from Crossref